A detailed history of Burt Wealth Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Burt Wealth Advisors holds 4,992 shares of BMY stock, worth $293,879. This represents 0.06% of its overall portfolio holdings.

Number of Shares
4,992
Previous 5,051 1.17%
Holding current value
$293,879
Previous $209,000 23.44%
% of portfolio
0.06%
Previous 0.06%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$39.66 - $51.75 $2,339 - $3,053
-59 Reduced 1.17%
4,992 $258,000
Q2 2024

Jul 16, 2024

BUY
$40.25 - $52.99 $442 - $582
11 Added 0.22%
5,051 $209,000
Q1 2024

Apr 18, 2024

BUY
$47.98 - $54.4 $7,196 - $8,160
150 Added 3.07%
5,040 $273,000
Q2 2023

Jul 18, 2023

SELL
$63.71 - $70.74 $22,171 - $24,617
-348 Reduced 6.64%
4,890 $312,000
Q1 2023

Apr 13, 2023

BUY
$65.71 - $74.53 $7,885 - $8,943
120 Added 2.34%
5,238 $363,000
Q4 2022

Jan 17, 2023

BUY
$68.48 - $81.09 $14,175 - $16,785
207 Added 4.22%
5,118 $368,000
Q3 2022

Oct 11, 2022

SELL
$0.13 - $76.84 $76 - $45,489
-592 Reduced 10.76%
4,911 $349,000
Q1 2022

Apr 19, 2022

SELL
$61.48 - $73.72 $13,218 - $15,849
-215 Reduced 3.76%
5,503 $402,000
Q4 2021

Jan 13, 2022

SELL
$53.63 - $62.52 $35,663 - $41,575
-665 Reduced 10.42%
5,718 $357,000
Q2 2020

Aug 05, 2020

BUY
$54.82 - $64.09 $1,151 - $1,345
21 Added 0.33%
6,383 $375,000
Q4 2019

Jan 29, 2020

BUY
$49.21 - $64.19 $21,898 - $28,564
445 Added 7.52%
6,362 $408,000
Q3 2019

Oct 31, 2019

SELL
$42.77 - $50.71 $7,484 - $8,874
-175 Reduced 2.87%
5,917 $300,000
Q1 2018

Apr 24, 2018

SELL
$59.92 - $68.98 $4,434 - $5,104
-74 Reduced 1.2%
6,092 $385,000
Q4 2017

Jan 30, 2018

BUY
$59.94 - $65.35 $4,435 - $4,835
74 Added 1.21%
6,166 $378,000
Q3 2017

Nov 09, 2017

SELL
$55.23 - $63.74 $48,326 - $55,772
-875 Reduced 12.56%
6,092 $388,000
Q2 2017

Aug 07, 2017

BUY
N/A
6,967
6,967 $388,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Burt Wealth Advisors Portfolio

Follow Burt Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burt Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Burt Wealth Advisors with notifications on news.